| Development of two high-performance liquid chromatographic methods for the analysis and characterization of insulin and its degradation products in pharmaceutical preparations A Oliva, J Fariña, M Llabrés Journal of Chromatography B: Biomedical Sciences and Applications 749 (1), 25-34, 2000 | 123 | 2000 |
| Comparative study of protein molecular weights by size-exclusion chromatography and laser-light scattering A Oliva, M Llabrés, JB Fariña Journal of pharmaceutical and biomedical analysis 25 (5-6), 833-841, 2001 | 105 | 2001 |
| New approach to stability assessment of protein solution formulations by differential scanning calorimetry M Cueto, MJ Dorta, O Munguı́a, M Llabrés International journal of pharmaceutics 252 (1-2), 159-166, 2003 | 86 | 2003 |
| Potential applications of PLGA film-implants in modulating in vitro drugs release MJ Dorta, A Santoveña, M Llabrés, JB Fariña International journal of pharmaceutics 248 (1-2), 149-156, 2002 | 81 | 2002 |
| In vivo–in vitro study of biodegradable methadone delivery systems CM Negrın, A Delgado, M Llabres, C Evora Biomaterials 22 (6), 563-570, 2001 | 80 | 2001 |
| Influence of temperature and shaking on stability of insulin preparations: degradation kinetics A Oliva, JB Fariña, M Llabrés International journal of pharmaceutics 143 (2), 163-170, 1996 | 78 | 1996 |
| Effect of high shear rate on stability of proteins: kinetic study A Oliva, A Santovena, J Fariña, M Llabrés Journal of Pharmaceutical and Biomedical analysis 33 (2), 145-155, 2003 | 76 | 2003 |
| One-month sustained release microspheres of 125I-bovine calcitonin: In vitro—in vivo studies RV Diaz, M Llabres, C Evora Journal of Controlled Release 59 (1), 55-62, 1999 | 72 | 1999 |
| Applications of multi-angle laser light-scattering detection in the analysis of peptides and proteins A Oliva, M Llabrés, JB Fariña Current drug discovery technologies 1 (3), 229-242, 2004 | 46 | 2004 |
| Stability study of human serum albumin pharmaceutical preparations A Oliva, A Santoveña, M Llabres, JB Fariña Journal of pharmacy and pharmacology 51 (4), 385-392, 1999 | 43 | 1999 |
| Rheological properties of PLGA film-based implants: correlation with polymer degradation and SPf66 antimalaric synthetic peptide release A Santovena, C Alvarez-Lorenzo, A Concheiro, M Llabres, JB Farina Biomaterials 25 (5), 925-931, 2004 | 42 | 2004 |
| Preparation and evaluation of insulin-loaded poly (DL-lactide) microspheres using an experimental design I Soriano, C Evora, M Llabrés International journal of pharmaceutics 142 (2), 135-142, 1996 | 38 | 1996 |
| Methadone implants for methadone maintenance treatment. In vitro and in vivo animal studies. CM Negrin, A Delgado, M Llabres, C Evora Journal of Controlled Release: Official Journal of the Controlled Release …, 2004 | 37 | 2004 |
| Effects of polymerization variables on PLGA properties: molecular weight, composition and chain structure MJ Dorta, O Munguia, M Llabres International Journal of Pharmaceutics 100 (1-3), 9-14, 1993 | 37 | 1993 |
| Biodegradable laminar implants for sustained release of recombinant human growth hormone JT Garcı́a, MJ Dorta, O Munguı́a, M Llabrés, JB Fariña Biomaterials 23 (24), 4759-4764, 2002 | 36 | 2002 |
| New trends in analysis of biopharmaceutical products A Oliva, JB Farina, M Llabres Current Pharmaceutical Analysis 3 (4), 230-248, 2007 | 29 | 2007 |
| In-vitro release of fluoropyrimidines from PLGA film implants MJ Dorta, A Oliva, O Munguía, M Llabrés, JB Fariña Journal of pharmacy and pharmacology 54 (6), 757-763, 2002 | 28 | 2002 |
| Fitting bevacizumab aggregation kinetic data with the Finke–Watzky two-step model: effect of thermal and mechanical stress A Oliva, M Llabrés, JB Fariña European Journal of Pharmaceutical Sciences 77, 170-179, 2015 | 27 | 2015 |
| A mathematical model for interpreting in vitro rhGH release from laminar implants A Santovena, JT García, A Oliva, M Llabrés, JB Farina International journal of pharmaceutics 309 (1-2), 38-43, 2006 | 25 | 2006 |
| Release control of albumin from polylactic acid microspheres I Soriano, M Llabres, C Evora International journal of pharmaceutics 125 (2), 223-230, 1995 | 24 | 1995 |
